Lupin Contributes Rs 21 crores in battle against COVID-19 Medical Dialogues Bureau13 April 2020 7:30 AM GMTMumbai: Lupin Limited has announced a contribution of INR 21 crores for relief efforts directed towards mitigating the COVID-19 crisis. Lupin's...
Lupin gets USFDA EIR for Nagpur Facility Medical Dialogues Bureau13 April 2020 5:32 AM GMTMumbai: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) after the closure of the U.S. FDA inspection of its...
Lupin launches Mycophenolic Acid Delayed-Release Tablets USP Medical Dialogues Bureau7 April 2020 7:42 AM GMTMumbai, Baltimore: Pharma major Lupin Limited (Lupin) announced the launch of Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg....
Lupin gets USFDA EIR for Aurangabad Facility Medical Dialogues Bureau4 April 2020 8:08 AM GMTMumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its...
Lupin gets USFDA EIR for Inhalation Research Center, Florida Medical Dialogues Bureau30 March 2020 9:34 AM GMTCoral Springs & Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S....
Mylan, Lupin Announce Positive CHMP Opinion for Nepexto Medical Dialogues Bureau29 March 2020 8:02 AM GMTHertfordshire, Pittsburgh, and Mumbai: Mylan N.V. and Lupin Limited (Lupin) has announced that the European Medicines Agency's Committee for Medicinal...
Lupin appoints Ramesh Swaminathan as CFO, Head Corporate Affairs Medical Dialogues Bureau27 March 2020 4:00 AM GMTMumbai: Pharma Major Lupin Limited (Lupin) announced the appointment of Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs....
Lupin launches Betamethasone Dipropionate Ointment USP (Augmented) Medical Dialogues Bureau23 March 2020 4:00 AM GMTIt is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13...
Lupin Receives International Sustainability Rating System (ISRS) Certification Medical Dialogues Bureau13 March 2020 6:50 AM GMTMumbai: Pharma major Lupin Limited has announced that the Company has received certification for International Sustainability Rating System (ISRS),...
Lupin bags India Pharma Leader Award at India Pharma 2020 and India Medical Device 2020 Conference Medical Dialogues Bureau11 March 2020 10:41 AM GMTMumbai: Lupin Limited won the coveted India Pharma Leader Award at the India Pharma 2020 and India Medical Device 2020 conference. This was...
Lupin Launches Authorized Generic version of Vimovo® delayed-release tablets Medical Dialogues Bureau6 March 2020 5:30 AM GMTThe product is a combination of naproxen, a non-steroidal anti-inflammatory drug (NSAID), and esomeprazole magnesium, a proton pump inhibitor (PPI)
Dr VG Somani DCGI releases IPA guidelines on Market Complaints. Medical Dialogues Bureau2 March 2020 5:00 AM GMTThe guidelines were released at the recently concluded India Pharmaceutical Forum
